Ledger.Open graph →
SEC Form D · filed March 10, 2026

SwitchPoint Bio Holding, Inc

Offering
$5.3M
Sold
$5.3M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
WILMINGTON, DE
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (3)

Jussi Paananen · Helsinki, H9Exec · DirectorDavid Proctor · Norcross, GADirectorSamuel Myllykangas · Espoo, H9Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗